Kenneth Bender

A new study confirms the ribavirin steady-state serum levels that correspond to high rates of efficacy and low adverse events.

A triple antiviral drug combination for the treatment of influenza significantly decreased viral shedding but failed to provide clinical benefit.

The American Society of Transplantation has reached a consensus on how the treatment of hepatitis C virus with direct-acting antivirals could enable organ transplantations to HCV-negative recipients.

The results of a new study show that when a best practice advisory (BPA) displayed in the electronic health record of patients in the baby boomer generation, it prompted a 5-fold increase in screening for hepatitis C virus (HCV) in this population.

Researchers from Harvard Medical School conducted one of the largest studies to date to examine the impact of pneumococcal vaccines and antibiotic usage on trends in colonization in young, healthy children.

The results of a new study have shown that an integrated care (IC) program can be successful in providing treatment to patients infected with hepatitis C virus (HCV) who were unlikely to respond to traditional outreach efforts.

A recent study finds that the use of sofosbuvir-based direct-acting antivirals for HCV treatment was effective and well-tolerated in elderly patients.

A report warns that liver failure might be associated with nine new direct-acting antivirals (DAA).